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ABSTRACT
The process of folding is a seminal event in the life of a protein, as it is essential for proper protein function 
and therefore cell physiology. Inappropriate folding, or misfolding, can not only lead to loss of function, 
but also to the formation of protein aggregates, an insoluble association of polypeptides that harm cell 
physiology, either by themselves or in the process of formation. Several biological processes have evolved 
to prevent and eliminate the existence of non-functional and amyloidogenic aggregates, as they are 
associated with several human pathologies. Molecular chaperones and heat shock proteins are specialized 
in controlling the quality of the proteins in the cell, specifically by aiding proper folding, and dissolution 
and clearance of already formed protein aggregates. The latter is a function of disaggregases, mainly 
represented by the ClpB/Hsp104 subfamily of molecular chaperones, that are ubiquitous in all organisms 
but, surprisingly, have no orthologs in the cytosol of metazoan cells. This review aims to describe the 
characteristics of disaggregases and to discuss the function of yeast Hsp104, a disaggregase that is also 
involved in prion propagation and inheritance. 
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INTRODUCTION
Protein Folding and MisFolding
Protein folding is considered to be the second half 
of a gene expression ‘game’ (Gierasch and King 
1990) because, in general, the proper function 
of a protein is reached when it adopts its native 
structure from the unfolded state (Ramos and 
Ferreira 2005, Dill and MacCallum 2012, Baldwin 
and Rose 2013). Following this perspective, the 
unfolded state is a large ensemble of conformations 
that folds to a stable conformation or native state, 
which is generally considered to comprise a 
unique conformation (Ramos and Ferreira 2005, 
Dill and MacCallum 2012, Baldwin and Rose 
2013). During folding the polypeptide chain can 
adopt several transient intermediate conformations 
before reaching a stable and lower favorable free 
energy level, sometimes referred to as a “valley” or 
“trough” in free energy, to complete folding. The 
resulting native protein structure corresponds to a 
unique biologically-active state, for which it has 
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been evolutionarily selected. However, especially 
inside the cell, the folding process is not without 
complications, and misfolding can not only cause 
loss of function, but also lead to aggregation (Finka 
and Goloubinoff 2013). This does not occur without 
biological consequences, since misfolded proteins 
and protein aggregation are strongly correlated 
with disease. 
Aggregates are soluble or insoluble non-
physiological associations of misfolded proteins 
via exposed hydrophobic regions (for reviews 
see Doyle et al. 2013, Knowles et al. 2014). 
Polypeptides can misfold into disordered or 
organized aggregates, one example of the latter 
being amyloids, that share a typical morphology 
(long, unbranched and often twisted structures 
with a few nanometers in diameter) where the core 
structure is composed of β-sheets whose strands 
run perpendicular to the fibril axis (Sunde and 
Blake 1997, Dobson 2004, Chiti and Dobson 2006). 
Some disordered aggregates and all amyloids are in 
a lower free energy state than the intended native 
form of the protein, rendering them incredibly 
stable. Furthermore, amyloid-like fibrils have 
other unique properties, such as being recognized 
by particular dyes and conformational specific 
antibodies (Vitrenko et al. 2007), and resistance to 
certain proteases and ionic detergent solubilization. 
These properties significantly prevent the 
solubilization and clearance of amyloids both in 
vivo and in vitro. 
The formation of amyloid-like fibrils by dam-
aged proteins is a characteristic of several neuro-
degenerative diseases, such as Huntington’s, Par-
kinson’s, Alzheimer’s, and prion related diseases 
(Ramos and Ferreira 2005, Chiti and Dobson 2006, 
Eisenberg and Jucker 2012). There are currently 
no effective treatments against these diseases, and 
their occurrence is strongly correlated with age due 
to progressive failure in the Protein Quality Control 
(PQC) system (see below) and because amyloids, 
like prions, can template further amyloid forma-
tion when in contact with soluble proteins. Such 
mechanisms in which direct phenotype inheritance 
is caused by changes in protein folding that are 
amyloidogenic in nature, also known as non-Men-
delian inheritance, are explained by the prion hy-
pothesis (Chien et al. 2004, Tuite and Serio 2010). 
In order for prion propagation to occur, a series 
of minimal requirements are needed. First, soluble 
polypeptides must become incorporated into prion 
complexes that have to be maintained. Secondly, 
prion complexes must seed new prion complexes, 
and lastly, prions have to be inherited by daughter 
cells, or transiently established into neighboring 
cells, and continue to propagate in the new cells. 
Inhibition of any of these steps results in prion loss 
or ‘curing’. 
However, it is important to point out that it is 
still controversial whether amyloid formation is 
cytotoxic or cytoprotective. A current hypothesis 
is that pre-amyloidogenic forms are the cytotoxic 
species and amyloid aggregates are innocuous 
(Arrasate et al. 2004, Shorter and Lindquist 2005, 
Cheng et al. 2007, Piccardo et al. 2007). For 
instance, melanin synthesis in humans is an example 
of functional amyloid-like structures working in a 
beneficial way (Fowler et al. 2006). Moreover, yeast 
prions are examples of non-cytotoxic aggregates 
under native protein expression conditions, and 
several studies have demonstrated that some yeast 
prions could be biologically beneficial (Lindquist 
1997), explained in more detail below. In any 
case, as discussed above, and elaborated upon 
further below in the context of prions, amyloid-
like aggregates have the ability to template more 
aggregates when in contact with soluble proteins.
Molecular chaPerones: holders, 
Foldases and disaggregases
In order to facilitate the correct folding, and prevent 
misfolding and aggregation, cells have evolved a 
complex quality control system formed by proteins 
known as heat shock proteins and molecular 
chaperones (for reviews see Douglas et al. 2009, 
Hartl et al. 2011, Tiroli-Cepeda and Ramos 2011, 
Kim et al. 2013, Priya et al. 2013). Chaperones 
exist in every cell and cell compartment and have a 
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key role in protein homeostasis and stress situations 
(Douglas et al. 2009, Hartl et al. 2011, Tiroli-Cepeda 
and Ramos 2011, Kim et al. 2013, Priya et al. 2013). 
These proteins can be understood and classified 
by the way they interact with substrates. By this 
classification, three general types of chaperones 
exist, referred to as holders (we use ‘holder’ 
instead of ‘holdase’ as the latter term implies an 
enzymatic activity which is not accurate, foldases, 
and disaggregases (Mayer 2010, Tiroli-Cepeda and 
Ramos 2011). Holders bind client proteins in an 
ATP-independent manner, named this way because 
they secure the client protein for further action by 
other chaperones, commonly a foldase, but can 
also independently protect against further protein 
misfolding or aggregation. Classical examples of 
holders are small Hsps (sHsps) and Hsp40s (Tiroli-
Cepeda and Ramos 2011). Foldases help the 
substrate adopt its native state in an ATP-dependent 
manner and are responsible for the major refolding 
activities in the chaperone system. Classical 
examples of foldases are chaperonin, Hsp70s and 
Hsp90s (Bukau and Horwich 1998, da Silva and 
Ramos 2012). Additionally, other chaperones and 
co-chaperones interact with foldases and modulate 
their respective activities in a dramatic way (Hartl 
et al. 2011, Tiroli-Cepeda and Ramos 2011, da 
Silva and Ramos 2012). 
Despite their broad chaperone activities, 
holders and foldases are unable to completely 
prevent the formation of aggregates inside the cell, 
and independently contain no remodeling activity 
on the aggregates that do form (Doyle et al. 2013). 
For cell survival, the reactivation of aggregated 
proteins can be viewed as more important than the 
mere elimination of aggregates, considering the 
significant energy and temporal requirements for de 
novo protein synthesis. The reactivation activity is 
performed by a specific subclass of disaggregases 
within the Hsp100 family, named ClpB/Hsp104, 
that have the remarkable ability to extricate protein 
monomers from aggregates in an ATP-dependent 
manner (Zolkiewski et al. 2012, Doyle et al. 2013). 
Additionally, all three of the chaperone activities 
described are intrinsically linked to each other. 
For example, the activities of many foldases are 
modulated by interactions with holders (Fan et al. 
2003, Summers et al. 2009a). Holders and foldases 
are unable to bind proteins within aggregates, so 
they rely on disaggregases to liberate protein clients 
from aggregates (Zolkiewski et al. 2012, Doyle et 
al. 2013). However, the ClpB/Hsp104 subfamily 
is not able to recover and refold the majority of 
protein substrates without the cooperation of the 
Hsp70 system, and this cooperation is highly 
specific, since disaggregation is contingent on the 
presence of Hsp70 and Hsp100 from the same, 
or highly related, species (Glover and Lindquist 
1998). Collectively, the cooperation of holders, 
foldases, and disaggregases is necessary to 
maintain a cellular environment free of potentially 
toxic aggregates (Fig. 1). 
Together with the proteostatic system, 
chaperones and Hsps form a PQC network that 
protects cells against misfolding and aggregation 
(Douglas et al. 2009, Tiroli-Cepeda and Ramos 
2011). Most of the members of this network are 
constitutively expressed, but their expression 
levels are considerably increased as a response to 
stress conditions. In a clever mechanism, many 
Hsps bind to the transcription factor that induces 
their own expression, HSF (heat shock factor), 
in the cytoplasm. This decreases the free cellular 
concentration of HSF, which in turn decreases 
HSF translocation to the nucleus, and subsequently 
reduces expression of Hsps (for a review see 
Morimoto 2011). The increase in misfolded 
proteins in the cytosol decreases the affinity of 
the Hsp/HSF complex, thereby freeing HSF for 
nuclear translocation. Unfortunately, the degree of 
the protective effect of the PQC network decreases 
with aging, mainly due to overloading and cellular 
damage throughout the years, allowing the 
formation of disordered aggregates and amyloids, 
which further aggravates cellular deterioration.
Abbreviations: HSF, heat shock factor; Hsp, heat 
shock protein; PD, Parkinson’s Disease; PQC, 
protein quality control.
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ClpB/Hsp104, A SUBFAMILY OF Hsp100
Chaperones that have disaggregase function 
are primarily classified within the ClpB/Hsp104 
protein subfamily of Hsp100s, and are all a subset 
of the AAA+ (ATPases Associated with various 
cellular Activities) superfamily of ATPases, a 
diverse class of proteins that provides a variety of 
other functions, including intracellular trafficking, 
cell cycle regulation, DNA replication, and protein 
degradation, among others (for reviews see Patel 
and Latterich 1998, Sauer et al. 2004, Snider and 
Houry 2008, Zolkiewski et al. 2012). Even though 
ClpB/Hsp104s are not essential under non-stress 
conditions, they confer protective qualities against 
various forms of stress, and have the remarkable 
ability to both resolubilize and reactivate aggregated 
proteins.
All members within the Hsp100 family, 
including ClpB and Hsp104, share several features, 
with some important differences. For example, all 
have an N-terminal Domain (NTD) that contributes 
to the high-binding affinity that Hsp100s have for 
aggregates, although the presence of the NTD is 
not an absolute requirement for thermotolerance 
(Beinker et al. 2002, Mogk et al. 2003, Barnett et 
al. 2005). Furthermore, the Hsp100 family may be 
divided into two classes, based on the presence of 
two (Class I) or one (Class II) nucleotide binding 
domains (NBDs). Each NBD contains canonical 
Walker A and B motifs and sensor-1, and -2 
motifs, which are important components in ATP 
binding and hydrolysis. The Hsp100 classes can 
be further divided according to the presence of a 
coiled-coil middle, or M domain, integrated within 
the first nucleotide binding domain. Although this 
domain is dispensable for the ATPase and protein 
translocating activities of unfolded substrates 
(Sielaff and Tsai 2010, Desantis and Shorter 2012), 
it is essential for reactivating protein aggregates. 
Specifically, this domain is composed of four anti-
parallel helices that are located on the outer surface 
and is flexible, moving in response to nucleotide 
binding as it participates in substrate interaction 
(Fig. 2; Lee et al. 2003, Schirmer et al. 2004). 
Figure 1 - Molecular chaperones and heat shock proteins can be classified by their interaction with substrates. a) Holders 
bind client proteins in an ATP-independent manner, named this way because they secure the client protein for further action by 
other chaperones, commonly a foldase, that coaxes the substrate into its native state in an ATP-dependent manner. In this figure, 
the holder is represented by an Hsp40 (PDB accession number 1C3G) that delivers a client protein (unfolded substrate) to the NBD 
of Hsp70 (PDB accession number 1HJO) (modified from Borges et al. 2012); SBD: substrate binding domain from Hsp70. b) 
Disaggregases have the remarkable ability to extricate protein monomers from aggregates in an ATP-dependent manner.
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The mobility of the M-domain is critical for the 
disaggregase function of ClpB (Lee et al. 2003) 
and Hsp70 has a role in shifting the M-domain 
away from the NBD1 that increases both the 
ATPase activity and the disaggregase activity of 
Hsp100 (Oguchi et al. 2012, Lipińska et al. 2013). 
Additionally, some mutations in the M domain of 
Hsp104 can potentiate its disaggregase and ATPase 
activities (Jackrel et al. 2014). 
Studies with Hsp104 have shown that the 
C-terminal region located after the second NBD 
is involved in oligomerization and co-chaperone 
interaction (Mackay et al. 2008). Orthologs of 
the Class I subfamily with an M-domain exist 
in bacteria (ClpB), yeast (Hsp104), and plants 
(Hsp101) (Lee et al. 1994, Queitsch et al. 2000, 
Cagliari et al. 2011), all of which are heat-induced 
and implicated in protein unfolding/disaggregation 
and degradation (Schirmer et al. 1996, Glover 
and Lindquist 1998, Dougan et al. 2002, Hodson 
et al. 2012, Winkler et al. 2012a). Surprisingly, 
metazoans lack a bona fide ClpB/Hsp100-like 
disaggregase in their cytosol (see below).
Figure 2 - ClpB/Hsp104. a) Schematic representation of the domains and motifs in Hsp100 proteins from the ClpB/Hsp104 
subfamily. Domains from N- to C-terminal: N-terminal, NBD1, Walker A, Walker B, Sensor-1, arginine fingers, M-domain, NBD2, 
Sensor-2 and C-terminal. b) Amino acid alignment of Escherichia coli ClpB and Saccharomyces cereviseae Hsp104. Gray patterns 
are the same as in A) (modified from Lee et al. 2003 and Shirmer et al. 2004).
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All Hsp100s self-assembly into ring-shaped 
structures and conformational changes are 
triggered by ATP binding and hydrolysis, which 
changes the positions of bound substrates relative 
to each other, followed by the translocation of the 
polypeptide through the central channel during 
aggregate reactivation (Weibezahn et al. 2004, 
Zolkiewski 2006). By using E. coli ClpB as a 
model, Schlieker et al. (2004) showed that the 
disaggregation mechanism involves continuous 
extraction of unfolded proteins from the aggregate 
that are solubilized into the central channel in a 
process called “threading”. Likewise, the hexameric 
structure of ClpB from Thermus thermophilus (Fig. 
1b) is crucial for its activity because it provides 
multiple sites for polypeptide substrate binding, 
which are translocated through its central channel 
during aggregate reactivation (Schirmer et al. 1996, 
Lee et al. 2003, Schlieker et al. 2004, Weibezahn 
et al. 2004, Zolkiewski 2006, Barends et al. 2010, 
Mayer 2010, Zolkiewski et al. 2012, Doyle et al. 
2013). The solubilized protein can then be refolded 
either spontaneously, or by a chaperone network 
independent of ClpB. It is important to emphasize 
that the extricated monomer, if not immediately 
refolded, could potentially reaggregate, especially 
in the presence of aggregate “seeds”, and thus 
overexpression of an Hsp100 could hypothetically 
increase the amount of aggregates. However, the 
resulting aggregate may be different and less toxic 
than the initial form, and in fact overexpression of 
some chaperones increases the amount of insoluble 
aggregates, which correlates with suppression of 
aggregate cytotoxicity (Douglas et al. 2008, Wolfe 
et al. 2014). Likewise, heterologous expression of 
an Hsp100 could increase aggregates, due to the 
absence of a native Hsp70/40 system with which 
to cooperate.
Although not a requirement, the presence of 
an Hsp70/40 system greatly enhances the ability 
of Hsp100 to bind and reactivate aggregates, 
suggesting the two systems may physically 
interact. Despite this, a stable complex between 
Hsp100 and  Hsp70 has not been observed to date, 
yet several lines of evidence exist that strongly 
support an interaction. First, as stated, Hsp100 
requires a synergistic interaction with Hsp70 and 
Hsp40 molecular chaperones to completely recover 
functional proteins from the majority of aggregates 
(Glover and Lindquist 1998, Goloubinoff et al. 
1999, Mogk et al. 1999). Secondly, there is kinetic 
evidence that suggests the interaction between 
Hsp70/DnaK with the aggregated substrate 
is the rate-limiting step of disaggregation. In 
addition, it has been well corroborated that the 
interaction between ClpB/Hsp104 and Hsp70 
forms a bichaperone system that is species-specific 
(Zietkiewicz et al. 2004, 2006, Glover and Lindquist 
1998, Schlee et al. 2004, Miot et al. 2011). For 
example, experiments have demonstrated that the 
replacement of the M-domain of yeast Hsp104 
with that of bacterial ClpB is sufficient to exchange 
the species specificity, allowing the yeast Hsp104 
chimera to cooperate with the bacterial Hsp70 
system in protein disaggregation and vice versa 
(Sielaff and Tsai 2010). These authors further 
demonstrated that the M-domain controls Hsp104 
function through direct interaction with the cognate 
Hsp70 system which is required to unleash the 
Hsp104 protein remodeling activity. As a final 
piece of evidence, both ClpB and Hsp104 require 
their Hsp70 counterparts for binding to some heat-
denatured aggregates and prion fibrils (Winkler et 
al. 2012b) (see below). 
In order to better understand the dynamics of 
protein disaggregation in the context of Hsp70 and 
Hsp40, we here provide a model for the cooperation 
between these proteins (Doyle et al. 2013) (Fig. 3). 
First, Hsp40, a holder, interacts with the aggregate 
and delivers it to the Hsp70 foldase. Hsp70 
then interacts with the surface of the aggregate 
by remodeling it to free exposed unstructured 
hydrophobic regions. Hsp104, a disaggregase, is 
then recruited by the Hsp70/aggregate complex and 
initiates the extraction of protein monomers from 
the aggregate by ATP coupled translocation through 
its central pore. This ATPase activity is stimulated 
by interactions involving the M-domain with 
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Hsp70. The unfolded polypeptide is subsequently 
released to refold either spontaneously, or with the 
aid of other chaperone machines.
YEAST Hsp104, A MOLECULAR CHAPERONE 
INVOLVED IN THE RECOVERY OF AGGREGATES 
AND PRION PROPAGATION AND INHERITANCE
One of the most studied Hsp100s is the Class I 
disaggregase from yeast (Hsp104) which, like all 
Hsp100s, plays a major role in the modification and 
dissolution of heat denatured protein aggregates 
(Parsell et al. 1994, Glover and Lindquist 1998, 
Bösl et al. 2006, Doyle et al. 2013). This protein was 
identified more than 20 years ago as a stress-induced 
chaperone vital for tolerance to heat and ethanol 
stresses, as well as to some heavy metals (Sanchez 
and Lindquist 1990, Parsell et al. 1991, Lindquist 
and Kim 1996), and seems to have a quaternary 
structure with subtle differences (Fig. 4) compared 
to T. termophilus ClpB (Wendler and Saibil 2010). 
Yeast knockouts of the hsp104 gene are viable, but 
have 100-1000-fold more mortality at 50 °C than 
wild-type, whereas knockouts transformed with 
the hsp104 gene recover thermotolerance (Sanchez 
and Lindquist 1990, Sanchez et al. 1992, Parsell 
et al. 1994). Additionally, Hsp104 is involved 
in replicative cell aging in yeast, specifically by 
being involved in the asymmetric segregation (and 
retention) of damaged carbonylated proteins in the 
progenitor cell. This ensures cellular juvenescence 
in the daughter cells by preventing inheritance of 
damaged and nonfunctional proteins in the progeny 
(Erjavec et al. 2007). 
Although purified Hsp104 is not capable of 
protecting luciferase against in vitro aggregation, it 
cooperates with Hsp70/Ssa1 and Hsp40/Ydj1 in a 
system that rescues and refolds protein aggregates 
even in vitro (Glover and Lindquist 1998), 
demonstrating that the chaperone is effective in 
dissociating already formed aggregates. Hsp104 
appears to be capable of functioning properly 
even under severe stress conditions, since it 
retains ATPase activity in low salt concentrations, 
high temperatures, and high concentrations of 
ethanol (Schirmer et al. 1998). In fact, Hsp104 
has a remarkable degree of operational plasticity 
compared to bacterial Hsp100 (ClpB). For example, 
it employs radically different mechanisms to 
remodel amyloid from disordered aggregates (see 
below), and can tolerate several defective subunits 
within the hexamer without undergoing a complete 
loss in activity (DeSantis et al. 2012). On the 
Figure 3 - A model for the cooperation between Hsp104, Hsp70 and Hsp40 to resolubilize aggregates. The chaperone system 
(Hsp40 and Hsp70, represented by black and light gray, respectively) identifies and associates with aggregates (1), from which 
Hsp104 can then interact directly through a small region of the Hsp104 M-domain (2), promoting interaction of Hsp104 with the 
aggregate. The sum of these interactions causes transmission of signals through the M-domain to NBD1, thereby coupling ATP 
hydrolysis to stimulate disaggregase activity by translocation through the central pore of Hsp104 (3). Following this, the unfolded 
polypeptide is released from Hsp104 and may spontaneously refold or is refolded to native protein with the assistance of other 
cellular chaperones (4) (modified from Miot et al. 2011).
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contrary, ClpB is relatively intolerant to defective 
subunits, and has limited activity against amyloid, 
albeit a higher ability to eliminate disordered 
aggregates compared to Hsp104 (DeSantis et al. 
2012). 
The function of Hsp104 is carefully 
choreographed by its two NBDs, which 
communicate with each other to coordinate 
its activity. Although they have low sequence 
homology to each other, both are required for 
thermotolerance, whereas NBD1 is involved in 
ATP hydrolysis and NBD2 is required for proper 
oligomerization, the reverse is true for bacterial 
ClpB and ClpA (Parsell et al. 1994, Singh and 
Maurizi 1994, Seol et al. 1995, Pak et al. 1999, Kim 
et al. 2000). Additionally, ADP is likely an inhibitor 
of the ATPase activity of Hsp104 (Kummer et al. 
2013) although, like ATP, the nucleotide stimulates 
oligomerization (Parsell et al. 1994, Hattendorf 
and Lindquist 2002). During function, Hsp104 
cycles between an ADP-bound state, which has low 
affinity for polypeptides, and an ATP-bound state, 
which has high affinity for polypeptides (Bösl et 
al. 2006). Doyle et al. (2007) reported that, even 
in the absence of other chaperones, a mixture of 
ATP and ATP-gamma-S, a slowly hydrolyzable 
nonphysiological ATP analogue, activates the 
resolubilization of aggregates by Hsp104. This 
activity is dependent on permissive ratios of ATP 
and ATP-gamma-S, since in the presence of ATP 
alone the activity is abolished. The reason for this is 
unclear, but likely due to ATP-gamma-S mimicking 
regulatory events in the Hsp104 machinery.  
Although mammals lack an apparent Hsp104 
ortholog, both yeast and mammals can carry prions, 
and Hsp104 is involved in yeast prion propagation 
and inheritance. Yeast prions resemble mammalian 
prions in their non-Mendelian inheritance and 
amyloid state (Chien et al. 2004, Inge-Vechtomov 
et al. 2007, Satpute-Krishnan et al. 2007, Tuite 
and Serio 2010) and are formed when soluble 
proteins are converted into an amyloid-like fibrilar 
structure and then act in the conversion of other 
soluble polypeptides into amyloids (Romanova 
and Chernoff 2009). All yeast prions identified to 
date are rich in glutamine and asparagine residues 
(Suzuki and Tanaka 2012). [PSI+] (Shorter and 
Lindquist 2004), [RNQ+] (also referred to as 
[PIN+]) (Sondheimer and Lindquist 2000), and 
[URE3+] (Masison and Wickner 1995, Moriyama 
et al. 2000), are the most studied yeast prions 
that are derived from native yeast proteins 
(Sup35p, Rnq1p, and Ure2p, respectively). Unlike 
mammalian prions, which are uniformly fatal, yeast 
prions are nonlethal when endogenously expressed 
under native conditions. Nonetheless, it is an open 
Figure 4 - Hexameric model for the Hsp100 family. Protomer cartoon representation of the structure of ClpB from 
Thermus thermophilus (PDB accession number 1QVR); hexamer cartoon and sphere representation (PDB accession 
number 4D2U) with detached protomer and the channel. Gray patterns in left are maintained: N-terminal, NBD1, 
M-domain and NBD2.
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question whether yeast prions are a biological 
benefit, such as behaving as capacitors of evolution 
(Lindquist 1997) or a biological burden (for a 
review see Wickner et al. 2011). In any case, each 
prion behaves differently when overexpressed. 
For example, overexpression of [PSI+] is toxic, 
not because of the aggregate itself, but because 
[PSI+] formation results in an inactive yet essential 
soluble translational termination factor from which 
it is derived (sup35) (Derkatch et al. 1997). On 
the other hand, [RNQ+] is toxic by its own nature 
(Douglas et al. 2008). In addition, both [PSI+] and 
[URE3+] prion strains induce the expression of 
Hsp104 and Hsp70, suggesting prion presence is 
stress inducing (Jung et al. 2000, Schwimmer and 
Masison 2002). 
Counterintuitively, elimination or inhibition of 
Hsp104 ‘cures’ the prion phenotype. (Chernoff et 
al. 1995, Wegrzyn et al. 2001). This is explained 
by the fact that Hsp104 acts by disassembling 
(seeding) amyloid fibers, thus generating more 
fibers that are transmitted to daughter cells 
during cell division (Collins et al. 2004, Tessarz 
et al. 2008). Prion severing is dependent on the 
ATPase activity of Hsp104, since its inhibition 
concomitantly inactivates the severing activity, 
curing prions by effectively serially diluting their 
cellular concentration during each mitotic division. 
This dilution creates “dead-end” aggregates 
(Wegrzyn et al. 2001). Likewise, the presence of 
small concentrations (1-5 mM) of guanidinium 
chloride (Gdm-Cl) can cure prions, since Gdm-Cl 
acts as an inhibitor of Hsp104. Although the action 
of Gdm-Cl is still not fully understood, its presence 
also decreases in vivo resolubilization of proteins 
and thermotolerance (Tuite et al. 1981, Ferreira 
et al. 2001) and it inhibits the ATPase activity of 
both Hsp104 and ClpB, but increases the ATPase 
activity of the latter while inhibiting the activity 
of the former (Grimminger et al. 2004, Nowicki et 
al. 2011, Kummer et al. 2013). This reversed effect 
could be explained by the functional inversion 
of the NBDs in Hsp104 and ClpB, previously 
described above. Curiously, ClpB is not capable of 
propagating [PSI+] in vivo, likely due to its inability 
to interact with the yeast Hsp70/Hsp40 system, and 
thereby demonstrating that the ability to remodel 
prions is not a global property of Hsp100s, and may 
even be prion specific (Tipton et al. 2008).
Sup35 (phenotype [psi-]), as mentioned, is a 
soluble translational termination factor in yeast that 
aggregates into an insoluble prionic state known 
as [PSI+], causing a reduction in the fidelity of 
translation termination, i.e. read through of stop 
codons, which is heritable (Paushkin et al. 1996, 
Uptain and Lindquist 2002). Where present and 
undisrupted, the [PSI+] phenotype continuously 
passes from generation to generation. [PSI+] is 
mediated via interactions at its N-terminal, which 
is rich in glutamine and asparagine residues, and 
middle domains, which are sufficient when in an 
amyloidogenic form to induce prion conversion 
(Tanaka et al. 2004). As with all yeast prions, 
[PSI+] maintenance and inheritance is dependent 
on Hsp104, and overexpression of Hsp104 cures 
the [PSI+] prion, but not [RNQ+] or [URE3+] 
(Wickner 1994).  More specifically, the N-terminus 
of Hsp104 is essential for [PSI+] prion curing, 
while dispensable for prion propagation, and the 
middle domain of Hsp104 is important for [PSI+] 
prion shearing (Hung and Masison 2006, Dulle et 
al. 2014). 
The conformational state of the Rnq1 protein, 
which has a prion domain at the C-terminus, 
determines the yeast prion [RNQ+] phenotype 
(Sondheimer and Lindquist 2000). The native 
function of Rnq1p is not clear, but the prion form 
interacts and helps other polypeptides, such as sup35 
and those with polyQ extensions, to form amyloid-
like aggregates in a process called prion cross-
seeding (Osherovich and Weissman 2001, Meriin 
et al. 2002, Taneja et al. 2007). In fact, the presence 
of [RNQ+] induces de novo appearance of [PSI+] 
by several fold (Derkatch et al. 1997, Kurahashi et 
al. 2011). Interestingly, [RNQ+] seems to need less 
Hsp104 activity to maintain transmissible forms 
when compared to Sup35 (Bardill et al. 2009), and 
mutations in the M-domain of Hsp104 affect the 
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propagation of [RNQ+] and [PSI+] differently. 
Another difference is that overexpression of Ssa1 
(yeast Hsp70) protects [PSI+] curing by Hsp104, 
and the addition of both Hsp70 and Sis1 (a yeast 
Hsp40) promotes the severing of [RNQ+] amyloid 
fibers and further prion seeding (Newnam et al. 
1999, Lopez et al. 2003, Douglas et al. 2008). In 
fact, all yeast prions discussed here require the 
presence of Sis1, but have different sensitivities 
to its depletion (Higurashi et al. 2008, Kirkland 
et al. 2011). The interactions of different yeast 
Hsp40s on the unique steps of prion propagation is 
complex and dependent on several factors. Hence, 
we do not provide a detailed description here (for 
an extensive review see Summers et al. 2009b). 
Ure2 is the protein determinant of the [URE3+] 
prion, and is responsible for repressing expression 
of nitrogen catabolic enzymes under abundant 
nitrogen conditions. Ure2 contains a globular 
C-terminal domain, and a highly disordered 
N-terminal domain, of which the latter is required 
for induction and propagation of the [URE3+] 
phenotype (Masison and Wickner 1995, Thual et 
al. 1999, Ngo et al. 2012). Ure2 is nonfunctional in 
the [URE+] form, but may form aggregates other 
than amyloids in vivo (Bousset et al. 2002, Ripaud 
et al. 2004). Expression of the yeast chaperones 
Ydj1 (a yeast Hsp40) and Ssa1 (yeast Hsp70) cures 
yeast of [Ure3+], but the cognate Sis1 Hsp40 and 
Ssa2/Hsp70 do not (Schwimmer and Masison 
2002, Sharma et al. 2009, Xu et al. 2013). It also 
appears that Hsp70 nucleotide exchange factors are 
important in determining the [URE3+] phenotype, 
as both Sse1p (a nucleotide exchange factor) and 
Snl1p can cure [URE3+], whereas deletion of 
Fes1p blocks [URE3+] propagation (Kryndushkin 
and Wickner 2007, Kumar et al. 2014). This ability 
is strongly coupled to interaction with Hsp70, since 
a Snl1p mutant with impaired affinity for Hsp70 
loses the ability to cure [URE3+] (Kumar et al. 
2014). 
Considering the above, the Hsp70/Hsp40 
system is important in the propagation of prions 
(Tipton et al. 2008, Newnam et al. 2011). For 
instance, Hsp40/Sis1 and Hsp70/Ssa bind to prions 
by themselves (Jung et al. 2000, Sondheimer et 
al. 2001) and also assist Hsp104 interaction with 
prions (Tipton et al. 2008). The ratio between 
Hsp104 and Hsp70 may lead to bipolar responses 
in prion severing: when the ratio between these 
chaperones is balanced, severing is favored, but 
when an excess of Hsp104 is present, severing 
is inhibited (Newnam et al. 2011). Additionally, 
overexpression of Hsp70/Ssa1 increases the loss 
of the [PSI+] phenotype and prevents curing by 
excess Hsp104 (Allen et al. 2005, Mathur et al. 
2009) whereas deletion of Hsp70/Ssa1 appears to 
have no effect on [PSI+] (Sharma and Masison 
2008). 
Other chaperones besides Hsp70 and Hsp40 
may also be important for the action of Hsp104 on 
prions and aggregates, since small Hsps are found 
to co-elute with Hsp104 (Duennwald et al. 2012). 
Hsp26, a small Hsp in yeast, collaborates with 
Hsp104 in the solubilization of polyQ aggregates 
(Cashikar et al. 2005). Small Heat shock proteins 
are also involved in assisting Hsp104 solubilization 
of polyQ aggregates in rats (Perrin et al. 2007). 
Hsp110/Sse1, a nucleotide exchange factor and co-
chaperone in yeast, is required for the formation 
and propagation of [URE3+] (Kryndushkin and 
Wickner 2007) and [PSI+] (Sadlish et al. 2008). 
On the contrary, Btn2 and Cur1 can cure most 
newly formed variants of [URE3+], likely by a 
sequestration mechanism (Wickner et al. 2014). 
Regarding interaction with other co-chaperones, 
the C-terminus of Hsp104 (41 residues long) 
is similar to the C-terminal motif of Hsp90 
that binds to co-chaperones containing a TPR 
(Tetratricopeptide Repeat). Immunoprecipitation 
studies have suggested that Hsp104 can also bind 
to these co-chaperones (Abbas-Terki et al. 2001). 
In fact, the Hop/Sti1 Hsp90 co-chaperone also 
appears to have some function in prion curing, as 
yeast cells deleted of Sti1 are less efficient in curing 
[PSI+] (Reidy and Masison 2010). In summary, 
the contrasting and sometimes bipolar responses 
of yeast prions to different chaperones and related 
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proteins strongly suggests that each prion variant 
possesses distinct propagation requirements, with 
the Hsp104/Hsp70/Hsp40 systems playing major 
roles in this process.
Since Hsp104 is important in yeast prion 
biology, it has been proposed that it could also 
be used as a potential therapeutic tool against 
prionic and amyloid diseases in metazoans, which 
apparently lack a true disaggregase ortholog. In this 
respect, Hsp104 has been reported to have strong 
activity against amyloids (unlike ClpB), (Vashist et 
al. 2010), and expression of Hsp104 in mammalian 
cells is well tolerated. In fact, there are several 
examples that demonstrate beneficial effects of 
expressing Hsp104 in models for neurodegenerative 
or prionic diseases. For example, Hsp104 has been 
shown to convert an aggregated and protease 
resistant mammalian prion-like protein fragment 
of PrPSc into a random coiled structure (Schirmer 
and Lindquist 1997, Liu et al. 2011). Additionally, 
Hsp104 inhibits the seeding properties of Abeta 
fibrils (Arimon et al. 2008), and is effective 
against protein aggregation (Mosser et al. 2004). 
Furthermore, the overexpression of Hsp104 in 
transgenic mice expressing the first 171 residues of 
mutant huntingtin, used as a model for Huntington’s 
disease, reduced the formation of aggregates and 
prolonged the lifespan of the animals (Vacher et 
al. 2005). When Hsp104 was introduced in a rat 
model of Parkinson’s disease, both reduction of 
aggregation and prevention of neurodegeneration 
caused by alpha-synuclein were observed (Bianco et 
al. 2008). Nonetheless, high Hsp104 concentrations 
are needed to mitigate human neurodegenerative 
diseases caused by protein substrates that Hsp104 
never naturally encounters. Recently, exciting work 
has demonstrated that Hsp104 can be potentiated 
by some mutations to induce potent gain-of-
function activities against aggregates of TDP-43, 
FUS, and alpha-synuclein (Jackrel et al. 2014). 
Therefore, heterologous expression of engineered 
Hsp104 could indeed be a therapeutic tool to treat 
amyloidogenic diseases in metazoans.  
SHIFTING PARADIGMS ON AGGREGATE 
RESOLUBILIZATION IN METAZOANS
It is surprising that unlike yeast and plants, 
metazoans lack a bona fide cytosolic ClpB/
Hsp104-like disaggregase. This is unexpected, 
since one would expect that such a mechanism 
would be present as an advantage against the 
deleterious actions of stress-induced and prion-
like aggregates, and metazoans are subject to the 
same types of stress as other organisms. Several 
hypotheses have been proposed to explain this 
absence, including the role of Q-rich amyloidogenic 
transcription factor complexes in animal signaling 
mechanisms, somatic cell differentiation, and even 
the role of disaggregases in some biosynthetic 
pathways (Erives and Fassler 2015). Disaggregase 
activities have been reported in crude extracts of 
mammalian cells and C. elegans (Bieschke et al. 
2009). However, these two studies were eventually 
partially retracted because it was determined that 
the activity was an artifact, resulting in surface 
adsorption of Abeta-fibrils to the plastic in multi-
well plates and Eppendorf tubes (Murray et al. 
2013). Conversely, the Hsp70/Hsp40 system alone 
is capable per se of dissolving small aggregate 
complexes, but requires the aid of Hsp100 to recover 
large aggregates (Diamant et al. 2000). Likewise, 
it was reported that Hsp110 (an Hsp70 homolog 
and not to be confused with Hsp100) synergizes 
with Hsp70 and Hsp40 to form a machine with a 
weak disaggregase activity in a cell free system. 
However, in this case the machinery was unable 
to degrade amyloid conformers, was dependent 
on the presence of all three proteins, and was mild 
when compared to the rapid disaggregase activity 
of Hsp104 (Shorter 2008, 2011). 
Hsp110 (Sse1/Sse2 in yeast) does seem to be 
involved in several physiological events involving 
protein aggregation. Hsp110 has a function 
similar to that of bacterial GrpE that facilitates 
the exchange of ADP for ATP inducing the release 
of the client protein bound to DnaK (bacterial 
Hsp70) (Dragovic et al. 2006, Raviol et al. 2006, 
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Kryndushkin and Wickner 2007) and associates 
with Hsp70 to form a disaggregase complex that 
is dependent on ATP and Hsp40 (Mattoo et al. 
2013). Interestingly, knockdown of Hs110 in mice 
causes accumulation of hyperphosphorylated tau (a 
characteristic of Alzheimer disease) (Eroglu et al. 
2010) and impairs the ability to refold luciferase 
(Yamagishi et al. 2011), whereas in C. elegans the 
dissolution of protein aggregates is compromised 
and the lifespan of the worms is shortened after 
heat shock (Rampelt et al. 2012). Besides being 
associated with aggregates, Hsp110 was enriched 
in a manner correlating with the relative toxicity of 
the aggregates when overexpressed in a human cell 
lineage (Olzscha et al. 2011). Other proteins also 
seem to collaborate with Hsp110 in a system that 
recovers protein aggregates in the cell, including 
HOP, and small Hsps (Rampelt et al. 2012, Mattoo 
et al. 2013, Torrente and Shorter 2014, Wolfe et al. 
2013). By overexpressing amyloid-like aggregates 
in a human cell model, Olzscha et al. (2011) showed 
that Hsc70 and its co-chaperones Hsp110, Hsp40/
Hdj1/2, and Bag2 associated with the aggregates. 
The fact that a disaggregase activity in 
metazoans evolved around the Hsp70/Hsp40 
system is not a surprise as this complex has a 
central role in the PQC system (Douglas et al. 
2009, Summers et al. 2009a, Tiroli-Cepeda and 
Ramos 2011) and associates with Hsp104 in 
yeast for full disaggregation activity (Glover and 
Lindquist 1998). As a matter of fact, human Hsc70 
and Hsp40/Hdj1 seem to display higher intrinsic 
disaggregation capacity than their yeast homologs, 
Hsp70/Ssa1 and Hsp40s Ydj1 and Sis1 (Rampelt 
et al. 2012).
One emerging possibility to compensate for 
the loss of Hsp104 is that metazoans may have 
evolved multiple systems that degrade protein 
aggregates with weak activities but with specific 
cellular or tissue specific localizations (Fig. 5). 
This is supported by a few lines of evidence. 
First, the loss of bona fide Hsp104 with the 
emergence of multicellular organisms is abrupt. 
Yet, coincidentally, several AAA+ proteins appear 
at this time in evolution with homology to the 
NBD2 of Hsp104, and many contain subcellular 
localization targeting sequences (Breakefield et al. 
2001, Torrente and Shorter 2014). 
For example, the Torsin protein family is absent 
in unicellular organisms and plants, but animals 
contain up to four members (A, B, 2A, and 3A) all 
containing an N-terminal endoplasmic reticulum 
targeting signal sequence, and a complete AAA+ 
module with Walker A, Walker B, sensor-1 and 
sensor-2 domains. Of all the torsins, torsin A is the 
most studied, since it is related to the progression 
of the neurological disorder known as dystonia, 
which has been mapped to a GAG nucleotide 
deletion that encodes a glutamate residue in the 
C-terminus of the torsinA gene product (Ozelius et 
al. 1997). Another intriguing feature of torsinA is its 
relationship with amyloidogenic neurodegenerative 
diseases, such as Parkinson’s disease (PD). For 
example, Lewy bodies that are predominant in 
the brains of PD patients contain both torsinA and 
synuclein (Shashidharan et al. 2000) and torsinA 
overexpression has been shown to prevent Lewy 
body formation and suppress polyglutamine 
aggregation in cellular and invertebrate models 
(Caldwell et al. 2003, McLean et al. 2002) 
Yet another interesting disaggregase candidate 
is called Skd3 (also referred to as the ClpB homolog), 
which is present in the genomes of several different 
organisms and shares many features with torsinA, 
to which it is an ortholog, including a complete 
AAA+ module with canonical Walker A, Walker B, 
sensor-1 and sensor-2 domains, and a subcellular 
localization prepeptide sequence (Skd3 to the 
mitochondria and Torsin A to the endoplasmic 
reticulum). In fact, the ClpB homolog is more 
closely related to Hsp104 by amino acid sequence 
than torsinA, sharing approximately 20% sequence 
identity with known Hsp104/ClpB members, which 
increases to 40% identity and 65% similarity within 
the single nucleotide binding domain (Jossé et al. 
2010). Interestingly, the ClpB ortholog contains up 
to four ankyrin repeats at the N-terminus, which 
is a unique feature not shared with either Hsp104 
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nor any member within the torsin family. In 
summary, several metazoan proteins may function 
cooperatively in different cellular compartments 
to eliminate protein aggregates in the cell, and we 
are just now beginning to understand which protein 
players are responsible for this activity. 
CONCLUSIONS
The formation of amyloid-like aggregates is 
associated with hundreds of diseases, many 
of which lack a therapeutic treatment or cure. 
The general accumulation of amyloid-like 
aggregates and prions inside the cell seems to 
have a proteotoxic effect, at least in the long 
term, because these species can template soluble 
proteins when in contact with them. Cells have a 
Protein Quality Control (PQC) system that deals 
with protein folding and misfolding. Among the 
proteins involved in the PQC, the ClpB/Hsp104 
family has captured broad attention because it 
has the formidable ability to ressolubilize and 
reactivate aggregated proteins. Although lacking 
a disaggregase specialist in its genome, metazoans 
have evolved one or more disaggregase-like systems 
around Hsp70 and its co-chaperones, that appears 
to be quite efficient in suppressing proteotoxicity 
in several cell lines. However, due to the sensitivity 
of metazoan cells to aging, this system may not 
be sufficient to compensate for the lack of an 
Hsp100-like chaperone, especially considering 
that the disaggregase machines in metazoans act 
much slower than Hsp104, and may be localized to 
specific cellular compartments (Shorter 2011).  
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RESUMO
O processo de enovelamento é um evento importante para 
o tempo de vida de uma proteína, uma vez que é essencial 
para a função adequada da proteína e, por conseguinte, 
para a fisiologia celular. Enovelamento inadequado, ou 
mau enovelamento, pode não só conduzir à perda de 
função, mas também para a formação de agregados de 
proteína, uma associação insolúvel de polipeptídos que 
prejudicam a fisiologia celular, quer por si próprios ou 
no processo de formação. Vários processos biológicos 
Figure 5 - Proposed Mechanism of Gene Loss and Gain in the Stem-metazoan Lineage as Applied to Disaggregase Activities. 
While Bona fide Hsp104 orthologs are highly conserved in bacteria, plants, yeast, and relatives of pre-metazoan containing 
receptor tyrosine kinases (RTKs), they are absent in modern metazoans. This may be due to a number of factors including loss 
of biosynthetic pathways requiring Hsp100s (Hsp104 and Hsp78), complex cell signaling involving amyloidogenic transcription 
factor (TF) complexes, and the specialization of hypothetical weak disaggregases with high specificities and localizations, such as 
the torsins in the endoplasmic reticulum (ER), and ClpBHH in the mitochondria. *RTKs = Receptor Tyrosine Kinases.
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têm evoluído para prevenir e eliminar a existência de 
agregados não funcionais e amiloidogênicos, uma vez 
que estão associados com várias patologias humanas. 
Chaperonas moleculares e proteínas de choque térmico 
são especializadas no controle de qualidade de proteínas 
na célula, especificamente, auxiliando o enovelamento 
correto, dissolução e remoção de agregados de proteína já 
formados. Esta última é uma função das ‘disagregases’, 
representadas principalmente pela subfamília ClpB/ 
Hsp104 de chaperonas moleculares, que são comuns 
em todos os organismos, mas, surpreendentemente, 
não possuem ortólogos no citosol de células de 
metazoários. Esta revisão tem como objetivo descrever 
as características das disagregases e discutir a função da 
Hsp104 de levedura, uma disagregase que também está 
envolvida na propagação e herança de príons.
Palavras-chave: amilóide, desagregase, proteínas 
do choque térmico, chaperonas moleculares, príons, 
enovelamento de proteínas.
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